Marker Therapeutics Inc (MRKR)

[microcapbiotech]

I believe pre the TPIV MRKR merger, as people were investigating what MRKR was and who ran it, there were discussions on several different stock message boards about both Viracyte, which became Allovir and Jounce because both companies had mutual founders or members on their scientific advisory boards.
In the case of Marker and Viracyte, the common connections were John Wilson and Ann Leen.
In the case of Marker and Jounce , the common connections were James Allison and Padmanee Sharma.
I believe at one time, I even suggested a 4 way merger, just for economies of scale and shared research and development costs and knowledge between Tapimmune, Marker, Viracyte and Jounce,
a la go big or go home.
Besides the common personnel, being aware of and following private biotech companies was not new to me. For many years I followed and waited for Moderna, Editas, Alnylam and Isis which changed it's name to Ionis for obvious reasons to go public, along with several others.
I have been following and investing in biotech since the 1980's. Did pretty good in the big picture.